New Once-Monthly Drug Cuts Cholesterol

Monday, 17 Mar 2014 12:35 PM

 

Share:
  Comment  |
   Contact Us  |
  Print  
|  A   A  
  Copy Shortlink

Amgen Inc said on Monday its experimental new type of cholesterol fighter met the primary goal of a late-stage trial by significantly cutting "bad" LDL cholesterol among patients with a genetic tendency towards very high levels of the artery clogging fat.
 
Amgen said patients given its injectable drug evolocumab once a month on top of standard daily statin treatments showed "clinically meaningful" improvement compared to statins alone after 12 weeks of treatment.
 
Evolocumab works by blocking PCSK9, a naturally occurring protein that keeps LDL levels elevated in the bloodstream. Other drugmakers, including Pfizer Inc and a partnership between Regeneron Inc and Sanofi, are racing with Amgen to complete trials of potentially lucrative anti-PCSK9 antibodies.
 
ALERT: 4 Things You'll Feel Before a Heart Attack


© 2014 Thomson/Reuters. All rights reserved.

Share:
  Comment  |
   Contact Us  |
  Print  
  Copy Shortlink
Around the Web
Join the Newsmax Community
Please review Community Guidelines before posting a comment.
>> Register to share your comments with the community.
>> Login if you are already a member.
blog comments powered by Disqus
 
Email:
Retype Email:
Country
Zip Code:
 
Hot Topics
Follow Newsmax
Like us
on Facebook
Follow us
on Twitter
Add us
on Google Plus
Around the Web
You May Also Like

Healthy Brown Fat Regulates Blood Sugar: Researchers

Friday, 25 Jul 2014 12:12 PM

Studies building the case for brown fat by focusing on its role in metabolism and healthy weight maintenance are rolling . . .

Manhunt for TB Patient Who May Be Spreading Disease

Friday, 25 Jul 2014 08:42 AM

Prosecutors in Northern California said Thursday that they have obtained an arrest warrant for a tuberculosis patient wh . . .

Parents of Obese Kids Often View Them as Healthy

Friday, 25 Jul 2014 08:26 AM

Parents of obese children often don't view their kids as unhealthy or recognize the health consequences of excess weight . . .

Most Commented

Newsmax, Moneynews, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, NewsmaxWorld, NewsmaxHealth, are trademarks of Newsmax Media, Inc.

 
NEWSMAX.COM
America's News Page
©  Newsmax Media, Inc.
All Rights Reserved